What is SpineGuard?
Founded in 2009, SpineGuard has established itself as a leader in the medical technology sector by focusing on the integration of its Dynamic Surgical Guidance (DSG) technology into routine orthopedic and neurosurgical procedures. The company's core mission is to secure and streamline skeletal implant placement, thereby reducing the risk of complications for patients and enhancing the efficiency of operating room workflows. By providing surgeons with real-time, actionable data, SpineGuard effectively bridges the gap between traditional surgical techniques and modern digital health requirements, positioning itself as an essential partner for healthcare providers globally.
How much funding has SpineGuard raised?
SpineGuard has raised a total of $28M across 4 funding rounds:
Stock Offering
$10.5M
Debt
$8.4M
Other Financing Round
$8M
Share Placement
$1.1M
Stock Issuance/Offering (2013): $10.5M, investors not publicly disclosed
Debt (2016): $8.4M led by IPF Partners and Bpifrance
Other Financing Round (2023): $8M supported by Nice & Green
Share Placement (2025): $1.1M, investors not publicly disclosed
Key Investors in SpineGuard
IPF Partners
IPF Partners is a prominent alternative financing provider focused exclusively on the healthcare sector, offering tailored debt and equity financing solutions for medtech and biopharma companies.
Bpifrance
Bpifrance is a French public investment bank that supports companies at every stage of their development through credit, guarantees, and equity to foster innovation and international growth.
Nice & Green
Nice and Green is a Swiss investment firm specializing in bespoke funding solutions and liquidity strategies for small and medium-sized enterprises across the European market.
What's next for SpineGuard?
With the recent injection of capital, SpineGuard is well-positioned to accelerate its commercialization strategy and deepen its penetration into key international markets. The company is expected to prioritize the standardization of its DSG technology as a clinical benchmark, leveraging its robust financial foundation to support ongoing research and development initiatives. By focusing on operational excellence and strategic partnerships, SpineGuard aims to solidify its market position, drive long-term value for shareholders, and continue its trajectory as a transformative force in the medtech landscape.
See full SpineGuard company page
